• 1. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
• 2. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Fe3O4/Au/Fe3O4 nanoflowers exhibiting tunable saturation magnetization and enhanced bioconjugation
  Feng Shi,Kunping Yan,Mingli Peng,Xiao Cheng,Yanling Luo,Xuemei Chen,V. A. L. Roy,Zuankai Wang Nanoscale, 2012,4, 747-751
• 5. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502

Comprehensive Guide to Nicotinic Acid-d1 (CAS 116975-14-5): Applications, Benefits, and Research Insights

Nicotinic Acid-d1, a deuterated form of nicotinic acid, is a specialized compound widely utilized in pharmaceutical research, metabolic studies, and analytical chemistry. With the CAS registry number 116975-14-5, this stable isotope-labeled variant offers unique advantages in tracing metabolic pathways and enhancing the precision of quantitative analyses. Researchers and industry professionals increasingly rely on Nicotinic Acid-d1 due to its role in drug development, biomarker discovery, and nutritional science.

The growing interest in deuterated compounds like Nicotinic Acid-d1 aligns with advancements in precision medicine and metabolomics. As scientists explore personalized therapies, the demand for isotopically labeled standards has surged. Nicotinic Acid-d1 serves as a critical tool for LC-MS (liquid chromatography-mass spectrometry) applications, enabling accurate measurements of nicotinic acid levels in biological samples. This capability is pivotal for studies on vitamin B3 deficiency, lipid metabolism, and cardiovascular health—topics frequently searched in academic and medical communities.

One of the most compelling applications of Nicotinic Acid-d1 lies in its use as an internal standard for pharmacokinetic studies. By incorporating deuterium, researchers minimize interference from endogenous compounds, ensuring reliable data in drug absorption and distribution analyses. This feature addresses a common challenge in bioanalytical method validation, a hot topic in regulatory science and FDA submissions. Laboratories worldwide prioritize such standards to comply with Good Laboratory Practice (GLP) guidelines.

Beyond pharmaceuticals, Nicotinic Acid-d1 plays a role in nutritional research. With rising public awareness of gut microbiome interactions and vitamin supplementation, scientists employ this compound to investigate how nicotinic acid derivatives influence microbial communities. Recent studies link vitamin B3 metabolites to inflammatory modulation—a trending subject in functional food development and dietary intervention strategies.

The synthesis of Nicotinic Acid-d1 involves sophisticated isotope enrichment techniques, ensuring high chemical purity and isotopic abundance. Manufacturers adhere to stringent quality control protocols, as even minor impurities can skew research outcomes. This attention to detail resonates with industries focused on traceability and material characterization, key concerns for purchasers evaluating CAS 116975-14-5 suppliers.

Environmental scientists also leverage Nicotinic Acid-d1 in ecotoxicology studies. Its stable isotope properties help track the environmental fate of nicotinic acid derivatives, addressing questions about biodegradation and water pollution—a pressing issue given increasing scrutiny of pharmaceutical residues in ecosystems. Such applications align with global initiatives like the UN Sustainable Development Goals (SDGs), particularly Goal 6 (Clean Water and Sanitation).

For analytical chemists, Nicotinic Acid-d1 exemplifies the convergence of green chemistry and high-throughput screening. Its use reduces the need for repetitive sample preparations, minimizing solvent waste—a priority for labs adopting Agile methodologies and automation. These efficiencies answer frequent search queries about cost-effective analytical workflows and lab sustainability practices.

In the diagnostic realm, Nicotinic Acid-d1-based assays contribute to biomarker validation for conditions like pellagra and hyperlipidemia. As point-of-care testing gains traction, the compound's stability under various storage conditions becomes invaluable. This reliability addresses a pain point in decentralized healthcare systems, where reagent longevity directly impacts diagnostic accuracy in resource-limited settings.

The market for isotope-labeled standards like Nicotinic Acid-d1 reflects broader trends in life sciences investment. Venture capital flows into proteomics and metabolomics platforms have created ripple effects across the supply chain. Procurement specialists often search for batch-to-batch consistency and regulatory documentation—factors that distinguish premium-grade CAS 116975-14-5 products from generic alternatives.

Future directions for Nicotinic Acid-d1 research may explore its potential in neurodegenerative disease models, given emerging links between NAD+ metabolism and conditions like Alzheimer's. Such interdisciplinary connections underscore why this compound remains a high-value research reagent with expanding applications across translational medicine and systems biology.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)